Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,838,770
+$11,276,942 QoQ
Shares Held
152,877
+13.1% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#64
of 629 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. JAZZ ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in JAZZ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,838,770 | 152,877 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $25,561,828 | 135,212 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,307,090 | 78,277 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,689,278 | 43,166 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,529,825 | 14,416 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,266,730 | 18,258 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,334,286 | 27,075 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,471,630 | 22,185 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,329,428 | 12,456 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,023,214 | 99,844 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,412,515 | 125,305 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,575,377 | 81,701 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $4,153,242 | 33,502 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $321,339 | 2,196 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $4,794,115 | 30,093 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $227,259 | 1,705 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $272,508 | 2,139 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $2,065,597 | 11,628 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,536,255 | 21,514 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,686,429 | 28,394 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,698,303 | 110,094 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,747,127 | 106,463 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $19,871,599 | 199,234 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||